We show that immune system of AD patients with non-IgE CMA demonstrates heightened responsiveness to microbial stimuli, as evidenced by increased serum CD14 levels and more robust immune responses to fungal antigens. The gene discussed is IGHE; the disease is Alzheimer disease.